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ABSTRACT  
Addiction is a complex disorder, and one characterised by the acquisition of maladaptive 
instrumental (drug-seeking and drug-taking) and pavlovian (cue-drug associations) 
memories. These memories markedly contribute to the long-term risk of relapse, so 
reduction of the impact of these memories on behaviour could potentially be an important 
addition to current therapies for addiction. Memory reconsolidation may provide such a 
target for disrupting well-consolidated pavlovian cue-drug memories following an extensive 
drug history. Reconsolidation can be disrupted either by administering amnestic drugs in 
conjunction with a memory reactivation session, or by updating the memory adaptively 
through the induction of ‘superextinction’. More work is needed before these therapies are 
ready for translation to the clinic, but if found clinically effective memory manipulation 
promises a radical new way of treating addiction. 
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INTRODUCTION 
Addiction is a chronic disorder associated with a long-term risk of relapse. Although 
complex, one increasingly dominant view in the addiction literature conceptualises the 
disease as one of aberrant learning and memory [1,2]. For this reason, there has been much 
interest in manipulating the maladaptive memories that underlie the long-term risk of 
relapse, by targeting the process of memory reconsolidation. This review will outline how 
maladaptive memories contribute to relapse risk in addiction, before going on to describe 
reconsolidation and how it might be used to disrupt drug memories. Finally, the feasibility of 
disrupting drug memories will be considered, by discussing how research conducted in 
animal models might be translated to a clinical setting. 
ADDICTION AS A DISORDER OF MALADAPTIVE LEARNING AND MEMORY 
Addiction can be conceptualised as a disorder of learning and memory [1,2]; the acts of 
drug-seeking and drug-taking are learned instrumental associations that occur in the 
presence of initially neutral environmental cues that become associated with the drug high 
through the process of pavlovian conditioning (Figure 1). These pavlovian conditioned 
stimuli (CSs) come to influence ongoing drug-seeking behaviour, and precipitate relapse in 
individuals trying to remain abstinent [3].  
 Pavlovian memories influence drug-seeking and relapse behaviour through at least 
three psychologically and neurobiologically distinct processes [4; Figure 1]. These processes 
– conditioned reinforcement, conditioned motivation and conditioned approach – support 
drug-seeking over delays to reinforcement, enhance ongoing drug-seeking, and bring the 
individual into the vicinity of where the drug-seeking response can be made [5] respectively. 
Thus, although relapse to drug-seeking is instrumental, it is influenced markedly by 
pavlovian associations that unconsciously influence behaviour.   
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 If maladaptive CS-drug memories contribute to maintaining drug-seeking and 
precipitating relapse, then manipulating these memories should reduce their effects on 
behaviour. Cue-exposure therapy, in which individuals are re-exposed to drug-associated 
stimuli in the absence of the drug high, aims to achieve these through ‘extinction’ (Figure 
2c). However, rather than ‘unlearning’ the original CS-US association, extinction instead 
involves the learning of a new, ‘CS-no US’ association [6]. Subsequently, the two associations 
compete for behavioural expression, with the original CS-US association being less 
contextually bound than the extinction memory. Thus, with a change in time, context or 
internal state through re-exposure to the US, the original CS-US memory can come to 
dominate behaviour again by spontaneous recovery, renewal or reinstatement [7]. Cue-
exposure therapy has had limited success in treating addiction, and although it may be 
possible to pharmacologically enhance the efficacy of extinction-based therapies [8,9], 
perhaps more effective would be strategies based upon manipulating the CS-drug memory 
itself. 
MEMORY MANIPULATION AS A POTENTIAL STRATEGY FOR TREATING ADDICTION 
The CS-drug memories underlying addiction are acquired through an extensive self-
administration history, and so are well-consolidated when patients present for treatment. In 
this situation, reconsolidation is a more feasible target for disruption than consolidation. 
Reconsolidation (Figure 2a) is the process by which previously consolidated memories are 
updated and maintained in the brain [10], following their reactivation (typically induced 
through memory retrieval in the laboratory). Following the initial demonstration of 
reconsolidation in the late 1960s [11,12], the process was little studied until the turn of the 
century [13]. However, with recognition of the importance of maladaptive memories in 
neuropsychiatric disorders, an increasing amount is becoming known about the molecular 
Milton 5 
and neurochemical mechanisms that underlie the reconsolidation process, and the boundary 
conditions that constrain it.  
THE DISRUPTION OF DRUG-MEMORY RECONSOLIDATION IN ANIMAL MODELS 
Animal models of addiction vary in their translational relevance, from procedures that use 
limited pairings of CSs and experimenter-administered drugs (e.g. conditioned place 
preference, or CPP) to behavioural tasks that involve hundreds of pairings of CSs with self-
administered drugs of abuse. Regardless of the model used, many studies have found that 
reconsolidation depends upon neurochemical signalling that is hypothesised to lead to 
increased expression of the plasticity-related immediate early gene zif268, and ultimately 
protein synthesis. 
PROTEIN SYNTHESIS AND INTRACELLULAR SIGNALLING CASCADES 
Consistent with previous work on fear memory reconsolidation [13], the reconsolidation of 
CS-drug memories is known to depend upon protein synthesis. Protein synthesis inhibition, 
in conjunction with memory reactivation, not only reduces subsequent preference for a 
previously cocaine-paired side in a CPP procedure [14,15] but also prevents a cocaine-
associated CS from acting subsequently as a conditioned reinforcer [16]. This mechanism is 
not specific to cocaine as a reinforcer, however, since protein synthesis inhibition at 
reactivation also disrupts CS-alcohol memories [17].  
 The proteins required for memory restabilisation are regulated by the expression of 
the plasticity-related immediate early gene zif268, which is critical for reconsolidation to 
occur [18]. Selective impairment of Zif268 protein expression using targeted antisense 
oligodeoxynucleotides prior to reactivation not only disrupted the reconsolidation of the 
memory underlying cocaine-conditioned place preference [19], but also prevented a 
cocaine-associated CS from subsequently acting as a conditioned reinforcer, similar to the 
effect seen with protein synthesis inhibition [16,19] and reduced the impact of a cocaine-
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associated CS on relapse to drug-seeking behaviour [20]. Protein synthesis, driven by Zif268 
expression, therefore appears critical for the reconsolidation of CS-drug memories. 
 The dual regulation of zif268 by both the cyclic AMP response element (CRE) and the 
serum response element (SRE) indicates that a number of intracellular signalling cascades 
can potentially activate its expression, though to date there have been few studies directly 
linking inhibition of specific pathways to the reduction of Zif268. It is known, for instance, 
that administration of a PKA inhibitor can prevent the CS-induced reinstatement of cocaine-
seeking [21] and that inhibition of extracellular-signal regulated kinase (ERK) prevents the 
reconsolidation of the memories underlying cocaine-conditioned place preference [15], but 
Zif268 levels were not assessed in these studies. The requirement for these intracellular 
protein kinases is also suggestive as to the neurochemical mechanisms of reconsolidation. 
NEUROCHEMICAL MECHANISMS  
Most studies investigating the neurochemical mechanisms underlying memory 
reconsolidation have focused on either β-adrenergic receptors (βARs) or the NMDA subtype 
of glutamate receptor (NMDARs). Both neurochemical systems have been linked to memory 
consolidation [22,23] and synaptic plasticity [24], and are required for the reconsolidation of 
pavlovian CS-fear memories [25,26]. Furthermore, there has been great interest in βAR-
mediated signalling because of the therapeutic potential of the βAR antagonist propranolol, 
which is already approved for human use. 
 Propranolol is effective at reducing, if not fully disrupting, the reconsolidation of CS-
drug memories. Propranolol disrupts the reconsolidation of the memories underlying 
cocaine-conditioned place preference [27], most likely by acting on central β2-adrenergic 
receptors [28]. However, the effects of propranolol on reconsolidation have been variable, 
particularly with regard to the number of treatment/reactivation sessions required for 
amnesia; single sessions are sufficient in some laboratories [27,28] but not others [29]. 
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Sometimes, for instance when targeting reconsolidation of the memories underlying a place 
preference conditioned to alcohol, propranolol does not appear to be effective at all [30]. 
These apparent inconsistencies may, in fact, reflect differences in the associations 
supporting the behaviour, in procedures that may differ slightly from one laboratory to 
another. 
 Self-administration models can be informative in this respect. Propranolol, given at 
reactivation, has been shown to reduce the capacity of a previously cocaine-associated CS to 
act subsequently as a conditioned reinforcer [31]. However, surprisingly, the same dose 
given to animals with a similar CS-drug history was ineffective at reducing CS-induced 
reinstatement of cocaine-seeking [32]. (Though it should be noted that propranolol does 
reduce the reinstatement of CS-induced alcohol-seeking when it is given in multiple 
treatment/reactivation sessions [33].) Analysis of CS-induced reinstatement procedures 
suggests that the effects of the drug-associated CS on instrumental behaviour could, in fact, 
be mediated by any one (or a combination) of the processes of conditioned reinforcement, 
conditioned motivation, or conditioned approach (Figure 1). Disruption of, for instance, the 
conditioned reinforcement memory alone may not reduce CS-induced relapse behaviour if 
conditioned motivation and approach could still act to support it [4]. It is relevant, therefore, 
that propranolol, given prior to reactivation, does not disrupt the reconsolidation of the CS-
alcohol memories that support conditioned motivation and conditioned approach [34]. A 
similar argument could be made for the apparently inconsistent findings with CPP 
procedures, since there has not been a detailed psychological or neurobiological analysis of 
the memories that support place preference, nor how much one association could 
potentially behaviourally compensate for another, disrupted one.  
 The dependence of CS-drug memory reconsolidation on NMDAR-mediated signalling 
has been more consistent. The NMDAR antagonist MK-801 has been shown to disrupt the 
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reconsolidation of the memories underlying cocaine CPP [35] and CS-induced relapse for 
cocaine [36] and alcohol [17,33]. An interesting point, from the perspective of the previous 
discussion, is that NMDAR antagonism at reactivation is effective at disrupting the memories 
that underlie conditioned motivation and conditioned approach for an alcohol-associated CS 
[34]. This may explain the different effects of NMDAR antagonism and βAR antagonism on 
CS-induced reinstatement [32]; as NMDAR antagonism can disrupt the reconsolidation of all 
‘three routes to relapse’, then after treatment, no pavlovian associations remain intact to 
influence instrumental behaviour. This is not the case with βAR antagonism, where only the 
memory underlying conditioned reinforcement is sensitive to disruption so, as suggested 
above, conditioned approach and conditioned motivation continue to support the influence 
of pavlovian CSs on relapse behaviour. 
BEHAVIOURAL THERAPIES: ‘SUPEREXTINCTION’ 
The disruption of CS-drug memories underlying relapse to drug-seeking behaviour may be a 
viable therapeutic strategy in the treatment of addiction. However, the development of 
pharmacotherapies appropriate for human use is not trivial, and although NMDAR 
antagonists have proven highly effective in animal studies, the psychotomimetic side effects 
of these drugs makes translation to clinical use difficult. An alternative ‘disruption’ strategy 
that has received much interest is the phenomenon of ‘extinction within the reconsolidation 
window’, or ‘superextinction’. Originally observed in studies of conditioned fear [37], though 
not universally replicated [38], superextinction refers to the updating of the original CS-US 
memory to a CS-no US association, rather than the learning of a separate, competing CS-no 
US memory, as in extinction (cf. Figure 2c and Figure 2d). Briefly, superextinction is induced 
by first initiating memory destabilisation through reactivation, similar to studies using 
pharmacological manipulations to disrupt reconsolidation. Following a short break in which 
the animal is removed from the reactivation context – typically lasting 10 minutes to 1 hour 
– the animal is returned to the same context to complete extinction training (Figure 2d) so 
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updating the old memory (with the information that the CS is now ‘safe’ in the case of CS-
fear memories). Pharmacological prevention of destabilisation has been shown to prevent 
the modulation of memory strength [39], and it is hypothesised that the introduction of the 
delay between the reactivation and extinction training phases alters the dynamics of the 
switch between the reconsolidation and extinction processes [40]. 
 The only demonstration to date of superextinction as a means of disrupting CS-drug 
memories is work by Xue and colleagues [41], who superextinguished the memories 
underlying both conditioned place preference and CS-induced relapse in animals previously 
trained to self-administer cocaine or heroin. Most remarkably of all, the superextinction 
treatment was also effective in preventing relapse for 6 months in human heroin addicts 
trying to maintain abstinence, when the investigators adapted standard cue-exposure 
therapy to incorporate the break between memory reactivation and extinction training. 
Though this study requires replication and further long-term follow-up, these findings are 
extremely encouraging for developing treatments for addiction based on manipulating 
maladaptive memories. 
TRANSLATION OF MEMORY MANIPULATION THERAPIES TO THE CLINIC 
Of course, the clinical translation of memory-manipulation treatments is not trivial, and 
further research is needed before treatments based on the manipulation of memories could 
be made widely available. One issue, previously alluded to, is the development of an 
appropriate amnestic agent if attempting to disrupt memory reconsolidation 
pharmacologically. Further research into the neurochemical systems underlying memory 
reconsolidation is needed to identify new drug targets, or more selective receptor 
antagonists could be developed by the pharmaceutical industry. Alternatively, this issue 
could be bypassed if the behavioural therapy of superextinction is consistently found to be 
effective.  
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 Another important consideration, for both pharmacological and behavioural 
manipulations of memory, is the understanding of boundary conditions, particularly 
between reconsolidation and extinction. A parametric study of memory reactivation is still 
lacking in the literature. In my laboratory, we have repeatedly found that behaviourally 
contingent reactivation sessions consisting of approximately 5-10% of total training 
exposures are effective in reactivating appetitive memories for cocaine, alcohol and sucrose, 
though it is not clear that these parameters are optimal. Understanding CS-drug memory 
reactivation and its relation to extinction is especially important, since pharmacological 
treatments that act to disrupt memory reconsolidation also often act to disrupt extinction, 
subsequently with opposite behavioural effects [26]. This is a pertinent issue for cue-
exposure therapy, since CS-drug memories are highly resistant to extinction [42]. Indeed, an 
attempt to use the NMDAR partial agonist D-cycloserine to enhance the extinction of 
cocaine-associated memories in a patient population actually increased subsequent craving 
for cocaine [43], consistent with enhancement of CS-cocaine memory reconsolidation 
dependent on Zif268 [44], rather than enhancement of extinction. 
 One final, but important, point to consider is the specificity of memory disruption. 
Though previous work has demonstrated relatively selective disruption of memory 
reconsolidation with pharmacological interventions [45,46], a recent study suggests that 
amnesia may not be selective when animals are trained on multiple tasks dependent upon 
the same brain structure. When mice were trained on both cocaine-conditioned place 
preference and an inhibitory avoidance task, it was found that the inactivation of the 
basolateral amygdala following reactivation of either the cocaine-place memory or the 
shock-place memory was sufficient to impair performance on both tasks [47]. It is not yet 
clear whether this finding is specific to the tasks used, or is indicative of a spreading amnesia 
when a neural locus required for more than one type of memory is targeted. This is 
especially relevant in the context of recent work suggesting that retrieval may not be a 
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necessary condition for memory destabilisation and reconsolidation; the processes of 
memory retrieval, destabilisation and restabilisation are, in fact, dissociable, at least for 
pavlovian conditioned fear memories [48]. Further research is required to determine how 
extensively memories are disrupted when a specific memory is targeted. 
CONCLUSIONS 
Addiction is a complex psychiatric disorder, and although maladaptive memories are only 
one aspect of addiction, they are extremely difficult to treat. Advances in understanding the 
mechanisms by which memories persist have identified that manipulation of drug memories 
may provide a promising therapeutic strategy for addiction, though more work is needed 
before this therapy could be implemented on a wide scale. 
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FIGURE LEGENDS 
Figure 1. Pavlovian CS-drug memories influence ongoing instrumental behaviour to maintain 
drug-seeking behaviour and to precipitate relapse. Individuals learn to make drug-seeking 
and drug-taking responses initially because the action is associated with the action of a drug 
high (though ultimately these responses can become divorced from the outcome, and so 
habitual). These instrumental memories are acquired in the presence of environmental 
stimuli that become associated with the drug in a pavlovian manner, and can influence 
instrumental behaviour by supporting approach towards the stimulus and where the 
instrumental response can be made (conditioned approach); by enhancing the motivation to 
make an instrumental response for the outcome (conditioned motivation, or pavlovian-
instrumental transfer) or by supporting responding over delays to reinforcement 
(conditioned reinforcement). The reconsolidation of the memories underlying these 
conditioned approach and conditioned motivation can be disrupted by antagonism at 
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NMDARs (red boxes) while that underlying conditioned reinforcement can be disrupted by 
antagonism at either NMDARs or βARs (red/blue box). 
Figure 2. Mechanisms of memory manipulation. (a) Reconsolidation is the process by which 
a previously consolidated memory in the ‘inactive state’ is converted (reactivated) to the 
‘active state’ through destabilisation mechanisms (normally induced in the laboratory by 
memory retrieval). These ‘active’ memories are subsequently restabilised back into the 
‘inactive’ state in a protein-synthesis dependent manner. (b) Disruption of reconsolidation 
(restabilisation) offers a therapeutic strategy for reducing the impact of maladaptive 
memories on behaviour. By combining memory reactivation (red box) with the 
administration of an amnestic agent (red ‘no’ sign), reconsolidation is blocked and the 
memory degrades from the unstable ‘active’ state. (c) Extinction does not require conversion 
between the ‘inactive’ and ‘active’ states of a memory, but instead is the learning of a new 
CS-no US memory. The two memories both persist in the brain and compete for behavioural 
expression, inhibiting each other. (d) ‘Superextinction’ exploits the reconsolidation process 
to rewrite old memories. By inducing memory reactivation (red box) and then, with an 
appropriate delay, introducing new information (red arrow), the memory is reconsolidated 
to persist in the ‘inactive state’ in the modified, updated form. 
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